INTERVIEW
How do you see the AI-driven advancements in endoscopy, radiology, and digital imaging changing the game in preventive and precision medicine?
AI-driven advancements in endoscopy, radiology, and digital imaging are fundamentally reshaping how we approach preventive and precision medicine. In radiology, AI-powered tools can detect even subtle abnormalities, often at an earlier stage than the human eye, which is especially critical for conditions like cancer and cardiovascular disease, where timely intervention can save lives. For countries like India, where specialist availability is limited, AI can help bridge the gap by assisting general practitioners and technicians with image interpretation, particularly in tier 2 and tier 3 cities. It is also becoming integral to large-scale screening programs for diseases such as breast cancer, tuberculosis, and liver disorders, enabling quick triaging of high volumes of scans for populationlevel interventions.
In endoscopy, AI is revolutionizing diagnostic accuracy and therapeutic decision-making. From boosting adenoma detection rates and lesion characterization in colonoscopy and assisting early cancer detection in the gastrointestinal tract, AI-assisted systems are increasing precision, minimizing fatigue, and supporting
clinicians for better patient care. Advanced computer-assisted diagnosis( CADx) systems are now capable of predicting lesion pathology and identifying infections like Helicobacter pylori, while also supporting personalized treatment planning in complex conditions such as inflammatory bowel disease.
How is FUJIFILM leveraging AI to deliver clinical accuracy and speed? What clinical challenges does ENDOVEDA, your AI-assisted endoscopy reporting platform, address and how is it being adopted across India?
Fujifilm is leveraging AI to bring a step-change in clinical accuracy, diagnostic speed, and workflow efficiency across imaging modalities. Our AI-powered platforms, such as ReiLI ® and Synapse ® AI, are designed to assist gastroenterologist and pulmonologist by detecting key clinical findings like tumors, lesions, or hemorrhages with high precision. Acting as a second set of eyes, these tools enhance diagnostic confidence, reduce variability, and help clinicians make faster, more informed decisions. Importantly, we focus on clinically validated and ethically deployed AI that complements human expertise rather than replacing it, a principle that guides our innovation roadmap.
While Endoveda™ is not an AI-
28
BioVoiceNews | September 2025